Qianqian Qi Selected Research

4Dm2m

6/2017	HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions.
5/2016	Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qianqian Qi Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2017
4	Cognitive Dysfunction 01/2021 - 10/2017
4	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2019 - 01/2017
4	Infections 10/2018 - 05/2016
2	Schistosomiasis (Bilharziasis) 01/2021 - 10/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2017
1	Pneumonia (Pneumonitis) 01/2022
1	COVID-19 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Stroke (Strokes) 01/2021
1	Cerebral Small Vessel Diseases 01/2021
1	Hepatitis B 10/2020
1	Bites and Stings (Sting) 01/2019
1	Schistosomiasis japonica 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Brain Ischemia (Cerebral Ischemia) 10/2017
1	Memory Disorders (Memory Loss) 10/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 06/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017

Drug/Important Bio-Agent (IBA)

3	Neuroprotective AgentsIBA 01/2019 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2017
2	AntigensIBA 10/2020 - 10/2018
2	4Dm2mIBA 06/2017 - 05/2016
1	Capsules (Microcapsules)IBA 01/2022
1	LigandsIBA 01/2022
1	HomocysteineIBA 01/2021
1	Hepatitis B e AntigensIBA 10/2020
1	imidazoleIBA 01/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	Pentetic Acid (DTPA)FDA LinkGeneric 01/2020
1	MicellesIBA 01/2020
1	PolymersIBA 01/2020
1	Therapeutic UsesIBA 01/2019
1	oxiracetamIBA 01/2019
1	RiboswitchIBA 01/2019
1	InterferonsIBA 01/2019
1	Interferon Type IIBA 01/2019
1	HydrogenIBA 01/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2018
1	3-n-butylphthalide (butylphthalide)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	EdaravoneIBA 01/2018
1	Phosphotransferases (Kinase)IBA 10/2017
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2017
1	Antiviral Agents (Antivirals)IBA 06/2017
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Nimodipine (Modus)FDA LinkGeneric 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Nelfinavir (Viracept)FDA Link 01/2017
1	HIV Protease InhibitorsIBA 01/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2021 - 10/2018
1	Quantum Dots (Quantum Dot) 01/2020
1	Photochemotherapy (Photodynamic Therapy) 01/2020